DR. AGNA MEERT
ActiveDR. AGNA MEERT has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €463k and a net result of €-90k. Equity is growing by ~11.5% per year across the filed fiscal years. Its solvency ranks better than 56% of 16414 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability0▼-90
Solvency100=
Growth52▼-26
Stability100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €24k at 30 days acceptable
Liquidity ample (current ratio 2.9 against 4.39 in 2024), and 30.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 7 filingsDeviation from the deadline
2025
31 d late
2024
30 d late
2023
29 d late
2022
29 d late
2021
31 d late
2020
111 d late
2019
122 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€463k▼ 33.1%
2024 · €693k
2019: €341k
2020: €458k
2021: €535k
2022: €597k
2023: €664k
2024: €693k
2019 → 2025
Total assets
€671k▼ 23.0%
2024 · €871k
2019: €495k
2020: €652k
2021: €668k
2022: €767k
2023: €818k
2024: €871k
2019 → 2025
Net result
€-90k
2024 · €125k
2019: €98k
2020: €117k
2021: €134k
2022: €136k
2023: €123k
2024: €125k
2019 → 2025
Working capital
€395k▼ 34.6%
2024 · €603k
2019: €336k
2020: €437k
2021: €522k
2022: €583k
2023: €645k
2024: €603k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€535k-€597k▲ 11.5%€664k▲ 11.2%€693k▲ 4.4%€463k▼ 33.1%
Operating result€187k-€203k▲ 8.7%€177k▼ 12.6%€164k▼ 7.5%€-96k
Net result€134k-€136k▲ 1.9%€123k▼ 9.5%€125k▲ 1.3%€-90k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €96k after €164k in 2024, the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €671k
Fixed assets
€69k▼ 23.0%
Current assets
€602k▼ 23.0%
Equity and liabilities €671k
Equity
€463k▼ 33.1%
Debt
€207k▲ 16.4%
The debt ratio rises from 20.5% to 30.9%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€-76k▼
2024 · €188k
Cash flow
€-70k▼
2024 · €149k
Solvency
69.1%▼
2024 · 79.5%
Current ratio
2.90▼
2024 · 4.39
Quick ratio
2.90▼
2024 · 4.39
Debt / equity
0.45▲
2024 · 0.26
ROE
-19.5%▼
2024 · 18.0%
ROA
-13.5%▼
2024 · 14.3%
Interest coverage
-236.94▼
2024 · 630.99
Debt
€207k▲
2024 · €178k
Debt ≤ 1 year
€207k▲
2024 · €178k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€871k€671k▼
Fixed assets21/28€89k€69k▼
Tangible fixed assets22/27€89k€69k▼
Plant, machinery and equipment23€10k€10k▼
Furniture and vehicles24€76k€56k▼
Other tangible fixed assets26€3k€3k▼
Current assets29/58€782k€602k▼
Amounts receivable after more than one year29-€303k
Other amounts receivable291-€303k
Amounts receivable within one year40/41€338k€58k▼
Other amounts receivable41€338k€58k▼
Cash at bank and in hand54/58€443k€240k▼
Deferred charges and accrued income490/1-€1k
Equity and liabilities
Total equity and liabilities10/49€871k€671k▼
Equity10/15€693k€463k▼
Contributions10/11€28k-
Reserves13€615k€505k▼
Distributable reserves133€615k€505k▼
Profit (loss) carried forward14€50k€-42k▼
Amounts payable17/49€178k€207k▲
Amounts payable within one year42/48€178k€207k▲
Current portion of amounts payable after more than one year42€2k-
Trade debts44€8k€6k▼
Suppliers440/4€8k€6k▼
Taxes, remuneration and social security45€5k€6k▲
Taxes450/3€5k-
Remuneration and social security454/9-€6k
Other amounts payable47/48€163k€196k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€24k€21k▼
Other operating charges640/8€26k€183k▲
Gross operating margin9900€215k€107k▼
Operating profit (loss)9901€164k€-96k▼
Financial income75/76B€6k€6k▼
Recurring financial income75€6k€6k▼
Financial charges65/66B€299€319▲
Recurring financial charges65€299€319▲
Profit (loss) for the period before taxes9903€170k€-90k▼
Income taxes67/77€45k-
Profit (loss) for the period9904€125k€-90k▼
Profit (loss) for the period to be appropriated9905€125k€-90k▼
Appropriation of the result
Profit (loss) to be appropriated9906€170k€-41k▼
Profit (loss) brought forward from the previous period14P€46k€50k▲
Transfer from equity791/2€95k€110k▲
Transfer to equity691/2€120k-
To other reserves6921€120k-
Profit to be distributed694/7€96k€111k▲
Return on contributions (dividend)694€96k€111k▲
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-12
Financial
Weakest financial yearnet €-90k ▼172%
Net result drops to €-90k, the lowest in the series.
30-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 30 days late
2024
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2022
31-12
Financial
Highest result since 2019net €136k ▲1.9%
Operating result €203k, net result €136k, both a record.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Equity above €500kEq €535k ▲16.9%
3 profitable years in a row build equity to €535k.
19-11
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 111 days late
2020
30-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 122 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Roosdaal · 1 establishment unit since 2006
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Derrevoortstraat 471760 RoosdaalGround area
1,038 m²
Building footprint
340 m²
Volume, LiDAR
1,707 m³
Parcel 23723B0325/00P000, Flanders · tallest building 7.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Derrevoortstraat 47, 1760 Roosdaal
since 20062.273.542.121
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23723B0325/00P000 | Flanders | 1,038 m² | 1 · 340 m² | 7.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Fontaine Michel anesthesie
BE 0831.396.205
Aalst · Eq €463k
DR. KOEN HULSMANS
BE 0776.886.163
Herk-de-Stad · Eq €463k
Dr. G. Vanspringel
BE 0860.040.107
Malle · Eq €463k
Dokter Giorgia Accorsi Anesthesist en Intensivist
BE 0786.788.477
Oostende · Eq €463k
Dr. M. DEVOOGHDT, RADIOLOOG
BE 0643.818.296
Ninove · Eq €463k
Of 16,603 companies in sector 86220 we hold annual accounts for 7,960. 6,471 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded27-12-2006
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.